ZBIO
NASDAQ HealthcareZenas BioPharma, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $24.50 |
|---|---|
| Volume | 290,774 |
| Market Cap | 1.32B |
| RSI (14-Day) | 37.7 |
| 200-Day MA | $22.39 |
| 50-Day MA | $23.21 |
| 52-Week High | $44.60 |
| 52-Week Low | $6.11 |
| P/E Ratio | 1.79 |
| Forward P/E | -6.22 |
| Price / Book | 5.27 |
🎯 Investment Strategy Scores
How ZBIO scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
29/100
High dividend yield + low volatility
🚀 Moon Shot
11/100
High growth potential (high beta + oversold)
🔪 Falling Knife
38/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
48/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
31/100
Large-cap, institutional-quality stocks
Find ZBIO in your text
Paste any text on the homepage — the tool will extract ZBIO and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.